Ovarian clear-cell carcinomas (OCCC) are known to be possibly resistant to platinum-based chemotherapy and to have a poorer prognosis with respect to other subtypes of epithelial ovarian cancer (EOC). This study was undertaken to compare response and survival to platinum-based chemotherapy between patients with advanced stage III and IV OCCC and serous EOC (sEOC).
Oncology Section, 2nd Department of Internal Medicine-Propaedeutic, University of Athens Medical School, Attikon University Hospital, 1 Rimini Street, Haidari, Gravias 5B, Aghia Paraskevi, Athens 15342, Greece. pectasid@otenet.gr